Skip to main content

Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder

  • 2023-09-22
  • Nutrients 15(19)
    • Ruixin Kou
    • Jin Wang
    • Angyang Li
    • Yuanyifei Wang
    • Bowei Zhang
    • Jingming Liu
    • Ying Sun
    • Shuo Wang

Abstract

Obesity has emerged as one of the most prevalent chronic diseases worldwide. Our study was conducted to investigate the anti-obese potential of novel probiotic Bifidobacterium longum subsp. infantis FB3-14 (FB3-14) and the underlying molecular mechanisms in high-fat diet (HFD)-fed mice. The results demonstrated that an 8-week FB3-14 intervention significantly suppressed the HFD-induced body and fat weight gain and abnormal alterations of the serum lipid parameter, restoring the levels of cholesterol (4.29 mmol/L) and low-density lipoprotein cholesterol (3.42 mmol/L). FB3-14 treatment also attenuated adipocyte expansion, hepatic injury, and low-grade systemic inflammation and restored the expressions of lipid-metabolism-related genes, including Hsl, Leptin, and Adiponectin. Furthermore, FB3-14 was observed to reduce the Firmicutes/Bacteroidetes ratio in obese mice; increase the abundance of Akkermansia muciniphila, unclassified_Muribaculaceae, Lachnospiraceae_NK4A136_group, and Bifidobacterim; and upregulate G protein-coupled receptor41 associated with higher levels of butyric acid. These results indicate the protective effectiveness of FB3-14 in HFD-driven obesity and gut microbiota disorders, highlighting the promising potential of FB3-14 as a functional nutrition supplement.

Keywords: Bifidobacterium longum subsp. infantis; gut microbiota; high-fat diet; lipid metabolism; liver function; obesity.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bifidobacterium longum UABI-14Normalized Serum Lipid LevelsBeneficial
Moderate
Bifidobacterium longum UABI-14Reduced Adipocyte SizeBeneficial
Moderate
Bifidobacterium longum UABI-14Reduced Inflammation LevelsBeneficial
Moderate
Bifidobacterium longum UABI-14Reduced Liver InjuryBeneficial
Moderate
Bifidobacterium longum UABI-14Restored Lipid MetabolismBeneficial
Moderate
⬆ Back to top
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Receive updates about our products, services, sales, and special offers. Unsubscribe anytime. See our Privacy Policy for details on how we handle your information.

Join Our Community

Use support@pillser.com to get in touch.